Cannabis could disrupt a $500 billion market, says CEO of top marijuana maker after deal with DEA

 

As we’ve said many times, one of the reasons cannabis remains illegal is because there are many vested interests that would prefer to keep it illegal. Some police, some Federal agencies, arguably the booze industry, but most of all Pharma are more than happy to keep pot illegal. It means money for them. It may mean billions for Pharma.

(From CNBC)

“The DEA-approved partner, which we haven’t announced yet, can actually begin to do medical research, clinical trials if necessary, [and] create the data set that enables people to know when, what, where, and maybe it can become federally regulated in the U.S. with some input that way,” Linton said in an interview on “Mad Money.”

Canopy’s news comes less than one month after competing Canadian marijuana producer Tilray announced DEA approval to import cannabis to the United States for medical research at the University of California San Diego Center for Medicinal Cannabis Research.

Notice that the DEA is the key player here. This may be part of a long term strategy for the agency. 

Click here for the article.